Literature DB >> 29289483

Challenges and future for the delivery of growth hormone therapy.

Andrés Caicedo1, Ron Rosenfeld2.   

Abstract

Growth hormone (GH) has multiple roles in sustaining human development and homeostasis. Its pulsatile secretion stimulates growth and contributes to an equilibrium in a process tightly regulated and coordinated by many organs. GH deficiency is a medical condition affecting all ages, with not only significant consequences in the health of the patient but also impact on the quality of life. This review gathers the different strategies used today with a glance at future technologies to treat GH deficiency. We present key aspects for consideration when developing new methods to deliver GH, mimicking or replacing its pulsatile activity. Today and in the future, the fusion of biochemistry, biology and nanotechnology will provide hybrid devices using microfluidic systems. But, until new technologies for GH delivery will become available, current methods must be reinforced in conjunction with the development of better communication strategies between the health system and patients. Treating GH deficiency represents a multidisciplinary effort for which this review provides a glance at potential future directions for this therapy.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Growth hormone; Micro Electromechanical Systems (MEMS); Organs-on-chips; Therapy; eHealth

Mesh:

Substances:

Year:  2017        PMID: 29289483     DOI: 10.1016/j.ghir.2017.12.008

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  1 in total

1.  Growth and Adult Height during Human Growth Hormone Treatment in Chinese Children with Multiple Pituitary Hormone Deficiency Caused by Pituitary Stalk Interruption Syndrome: A Single Centre Study

Authors:  Fengxue Wang; Jinyan Han; Zengmin Wang; Xiaohong Shang; Guimei Li
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-09-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.